申请人:Merck Sharp & Dohme Ltd.
公开号:US05614524A1
公开(公告)日:1997-03-25
A class of substituted piperazine derivatives of formula I ##STR1## are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated conditions, for which a selective agonist of these receptors is indicated.
一类化学式I的取代哌嗪衍生物是5-HT.sub.1-样受体的选择性激动剂,因此在临床情况的治疗中特别适用于偏头痛及相关症状,需要这些受体的选择性激动剂。